Your browser doesn't support javascript.
loading
KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.
Simó-Riudalbas, Laia; Pérez-Salvia, Montserrat; Setien, Fernando; Villanueva, Alberto; Moutinho, Catia; Martínez-Cardús, Anna; Moran, Sebastian; Berdasco, Maria; Gomez, Antonio; Vidal, Enrique; Soler, Marta; Heyn, Holger; Vaquero, Alejandro; de la Torre, Carolina; Barceló-Batllori, Silvia; Vidal, August; Roz, Luca; Pastorino, Ugo; Szakszon, Katalin; Borck, Guntram; Moura, Conceição S; Carneiro, Fátima; Zondervan, Ilse; Savola, Suvi; Iwakawa, Reika; Kohno, Takashi; Yokota, Jun; Esteller, Manel.
Afiliación
  • Simó-Riudalbas L; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Pérez-Salvia M; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Setien F; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Villanueva A; Translational Research Laboratory, Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Catalonia, Spain.
  • Moutinho C; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Martínez-Cardús A; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Moran S; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Berdasco M; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Gomez A; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Vidal E; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Soler M; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Heyn H; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Vaquero A; Chromatin Biology Group, IDIBELL, Barcelona, Catalonia, Spain.
  • de la Torre C; Proteomics Unit at PEBC, IDIBELL, Barcelona, Catalonia, Spain.
  • Barceló-Batllori S; Proteomics Unit at PEBC, IDIBELL, Barcelona, Catalonia, Spain.
  • Vidal A; Department of Pathology, Bellvitge University Hospital, IDIBELL, Barcelona, Catalonia, Spain.
  • Roz L; Tumor Genomics Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pastorino U; Thoracic Surgery Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Szakszon K; Institute of Pediatrics, Clinical Genetics Center, University of Debrecen, Debrecen, Hungary.
  • Borck G; Institute of Human Genetics, University of Ulm, Ulm, Germany.
  • Moura CS; Department of Pathology, Centro Hospitalar de São João, Porto, Portugal.
  • Carneiro F; Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and Medical Faculty of University of Porto, Porto, Portugal.
  • Zondervan I; MRC-Holland, Amsterdam, the Netherlands.
  • Savola S; MRC-Holland, Amsterdam, the Netherlands.
  • Iwakawa R; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
  • Yokota J; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan. Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Catalonia, Spain.
  • Esteller M; Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain. Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. Institucio Catalana de Recerca i
Cancer Res ; 75(18): 3936-45, 2015 Sep 15.
Article en En | MEDLINE | ID: mdl-26208904
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Pequeñas / Histona Acetiltransferasas / Neoplasias Pulmonares / Proteínas de Neoplasias Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Pequeñas / Histona Acetiltransferasas / Neoplasias Pulmonares / Proteínas de Neoplasias Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article País de afiliación: España